MED27
protein-codingmediator complex subunit 27, the group of Mediator complex
Gene summary
The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 5. [provided by RefSeq, Dec 2011]
- CRSP8
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~226.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0859137
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0859137
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0859137
Submitter: ClinGen
The *MED27* gene is located on chromosome 9 at 9q34.13 and encodes a subunit of the Mediator multiprotein complex, which is involved in transcriptional regulation (PMID 9989412). *MED27* was first reported in relation to autosomal recessive neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia in 2021 (Meng et al., PMID: 33443317). Eighteen unique variants (13 missense, 1 in-frame deletion, 3 frameshift, and 1 splicing) that have been reported in 32 probands across three publications (PMIDs: 33443317, 37517035, 39296199, SCV003804874.2) are included in this curation. Variants in this gene segregate with disease in families with multiple affected family members. The mechanism of pathogenicity is reported to be loss of function (PMID: 16582438). This gene-disease relationship is also supported by experimental evidence (biochemical, protein interactions and animal models) (PMIDs: 9989412, 37516429, 16582438, 36305825, 30091705, 31613003, 40578305, 40524219). Other genes that code for mediator complex subunits (*MED12*, *MED13*, *MED13L*, *MED17*, *MED25* and *CDK8*) are definitively or strongly associated with conditions involving developmental, language and motor delay, intellectual disability, seizures, cataracts and microcephaly. A knockout zebrafish model showed a reduction in head size and abnormal neurological development (PMID: 16582438). A second knockout zebrafish showed *MED27*’s role in neurogenesis and cerebellar development through motor impairments, reduced GABAergic neurons, failed neurogenesis, and defective progenitor cell differentiation (PMID: 40578305). An additional homozygous mutant zebrafish displayed severe developmental defects, motor deficits, and cerebellar atrophy which are clinical features seen in patients with *MED27* pathogenic variants (PMID: 40524219). Early lethality was observed in *MED27* gene knockouts in mouse, fruit fly and chicken (PMIDs: 36305825, 30091705, 31613003). While these latter three models do not necessarily recapitulate the disease phenotype, the observation that no reported human cases have been homozygous or compound heterozygous for loss-of-function variants suggests that complete loss of function of *MED27* may be embryonically lethal. In summary, there is definitive evidence to support the relationship between *MED27* and autosomal recessive neurodevelopmental disorder with spasticity, cataracts, and cerebellar hypoplasia. This gene-disease pair was originally evaluated by the ClinGen Syndromic Disorders GCEP on 12/15/2023. It was re-evaluated on 12/03/2025. As a result of this reevaluation, the classification increased from Strong to Definitive with the addition of a new case report and two zebrafish knockout models (PMIDs: 39296199, 40524219, 40578305). (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0859137
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MED27 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004269.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 5 | 6 | |||
| missense | 1 | 2 | 31 | 3 | 37 | |
| nonsense | 2 | 4 | 6 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 3 | 5 | ||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 3 | 5 | 42 | 8 | 0 | 58 |
Highest pathogenic variant AF is 0.000019222613
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004260.2 | 8 | MANE Select | |
| Ensembl | ENSP00000292035.5 | 8 | MANE Select | |
| RefSeq | NP_001240810.1 | 7 | Standard | |
| RefSeq | NP_001240811.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thyroid hormone signaling pathway - Homo sapiens (human)
- Developmental Biology
- Gene expression (Transcription)
- Generic Transcription Pathway
- RNA Polymerase II Transcription
Biological Process
- regulation of transcription by RNA polymerase II
- transcription initiation from RNA polymerase II promoter
- protein ubiquitination
- stem cell population maintenance
- positive regulation of nucleic acid-templated transcription
Molecular Function
- transcription coactivator activity
- protein binding
- ubiquitin protein ligase activity
Cellular Component
- ubiquitin ligase complex
- nucleus
- nucleoplasm
- transcription factor complex
- nucleolus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000292035
- Coding exons
- 8
- Length
- 219802
- Individuals with no LoFs
- 125716
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 125748
- p
- 0.000127
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.26 | 131 | 179 | 0.734 | 0.00000971 | 2029 |
| Missense (PolyPhen) | 21 | 44.504 | 0.47187 | 466 | ||
| Synonymous | 0.0300 | 70 | 70.3 | 0.995 | 0.00000381 | 599 |
| Loss of Function | 1.52 | 10 | 16.7 | 0.599 | 8.60e-7 | 190 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00017 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00018 | 0.00018 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. {ECO:0000269|PubMed:10882111, ECO:0000269|PubMed:9989412}.;
Recessive Scores
- pRec
- 0.109
Intolerance Scores
- LoFtool
- 0.371
- RVIS EVS
- -0.47
- RVIS percentile EVS
- 23.04
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.731
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |